Frontiers in Cardiovascular Medicine (Aug 2024)
Editorial: Inflammation in ischemic heart disease: pathophysiology, biomarkers, and therapeutic implications
- Luigi Cappannoli,
- Luigi Cappannoli,
- Mattia Galli,
- Mattia Galli,
- Josip Andelo Borovac,
- Emanuele Valeriani,
- Francesco Maria Animati,
- Francesco Fracassi,
- Francesco Fracassi,
- Francesco Burzotta,
- Francesco Burzotta
Affiliations
- Luigi Cappannoli
- Department of Cardiovascular Sciences, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy
- Luigi Cappannoli
- Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Mattia Galli
- GVM Care & Research, Maria Cecilia Hospital, Cotignola, Italy
- Mattia Galli
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
- Josip Andelo Borovac
- Division of Interventional Cardiology, Cardiovascular Diseases Department, University Hospital of Split (KBC Split), Split, Croatia
- Emanuele Valeriani
- Department of General Surgery and Surgical Specialty, Sapienza University of Rome, Rome, Italy
- Francesco Maria Animati
- Department of Cardiovascular Sciences, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy
- Francesco Fracassi
- Department of Cardiovascular Sciences, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy
- Francesco Fracassi
- Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Francesco Burzotta
- Department of Cardiovascular Sciences, Università Cattolica del Sacro Cuore (UCSC), Rome, Italy
- Francesco Burzotta
- Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- DOI
- https://doi.org/10.3389/fcvm.2024.1469413
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords